Austin Repatriation Hospital
Welcome,         Profile    Billing    Logout  
 4 Trials 
6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Woodward, Michael
ATTENTION-AD, NCT04314934: OLE of Phase 2b/3 Study ANAVEX2-73-AD-004

Completed
2/3
300
Europe, Canada, RoW
ANAVEX2-73, Blarcamesine
Anavex Life Sciences Corp., Anavex Australia Pty Ltd., Anavex Germany GmbH
Alzheimer Disease
06/24
06/24
PROGRESS-AD, NCT06079190: Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease

Active, not recruiting
2
359
Europe, Canada, US, RoW
GSK4527226, Placebo
GlaxoSmithKline, Alector Inc.
Alzheimer's Disease
11/26
11/26
TACUNA, NCT04617938: (Traditions and Connections for Urban Native Americans)

Active, not recruiting
N/A
541
US
TACUNA plus Wellness Circle, Opioid Education Workshop
RAND, University of California, Los Angeles, Sacred Path Indigenous Wellness Center
Opioid Use, Alcohol Drinking, Marijuana Use
03/25
07/25
Skoff, Kathy
ACTRN12605000119695: Randomised Phase II trial of irinotecan with hyaluronic acid (HyCAMP) versus irinotecan as treatment for patients with metastatic colorectal cancer who have failed 5-FU based chemotherapy

Recruiting
2
86
 
Meditech Research Limited
Metastatic colorectal cancer
 
 
Zeimer, Henry
RETHINK-1, NCT04994483: Simufilam 100 Mg for Mild-to-Moderate Alzheimer's Disease

Completed
3
804
Canada, US, RoW
Simufilam, PTI-125, Placebo
Cassava Sciences, Inc., Premier Research Group plc
Alzheimer Disease
10/24
10/24
NCT06114745: A Trial of SHR-1707 Infusion in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease

Active, not recruiting
1
12
RoW
SHR-1707 injection, Placebo
Atridia Pty Ltd.
Alzheimer's Disease (AD)
11/25
11/25
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Woodward, Michael
ATTENTION-AD, NCT04314934: OLE of Phase 2b/3 Study ANAVEX2-73-AD-004

Completed
2/3
300
Europe, Canada, RoW
ANAVEX2-73, Blarcamesine
Anavex Life Sciences Corp., Anavex Australia Pty Ltd., Anavex Germany GmbH
Alzheimer Disease
06/24
06/24
PROGRESS-AD, NCT06079190: Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease

Active, not recruiting
2
359
Europe, Canada, US, RoW
GSK4527226, Placebo
GlaxoSmithKline, Alector Inc.
Alzheimer's Disease
11/26
11/26
TACUNA, NCT04617938: (Traditions and Connections for Urban Native Americans)

Active, not recruiting
N/A
541
US
TACUNA plus Wellness Circle, Opioid Education Workshop
RAND, University of California, Los Angeles, Sacred Path Indigenous Wellness Center
Opioid Use, Alcohol Drinking, Marijuana Use
03/25
07/25
Skoff, Kathy
ACTRN12605000119695: Randomised Phase II trial of irinotecan with hyaluronic acid (HyCAMP) versus irinotecan as treatment for patients with metastatic colorectal cancer who have failed 5-FU based chemotherapy

Recruiting
2
86
 
Meditech Research Limited
Metastatic colorectal cancer
 
 
Zeimer, Henry
RETHINK-1, NCT04994483: Simufilam 100 Mg for Mild-to-Moderate Alzheimer's Disease

Completed
3
804
Canada, US, RoW
Simufilam, PTI-125, Placebo
Cassava Sciences, Inc., Premier Research Group plc
Alzheimer Disease
10/24
10/24
NCT06114745: A Trial of SHR-1707 Infusion in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease

Active, not recruiting
1
12
RoW
SHR-1707 injection, Placebo
Atridia Pty Ltd.
Alzheimer's Disease (AD)
11/25
11/25

Download Options